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1. Introduction 
Hyperthyroidism can induce skeletal muscle weak- 
ness and atrophy [ 1,2]. These clinical signs could be 
explained by increased proteolysis in hyperthyroid 
muscle [3,4], and it might be reasonable to assume 
that the protein degradation is due to increased activ- 
ities of proteases present in muscle tissue. 
However, relatively few proteases have been defined 
which have the property of degrading myofibrillar 
proteins. Here we report increased activities in hyper- 
thyroid skeletal muscle of calcium-activated neutral 
protease (CANP), cathepsin B and D. CANE’ is included 
in the cytosol fraction [5], is activated by Ca*’ at 
neutral pH [6,7] and is inhibited with leupeptin or 
antipain [8]. Both cathepsin B and D are contiined in 
the lysosome fraction [9,10] and are active at acidic 
pH [9-111. 
These proteases are important, since CANP has 
been shown to degrade both tropomyosin and troponin 
[6-81 and cathepsin B and D have been demonstrated 
to destroy both myosin and actin among myofibrillar 
proteins [ 111. The mechanism of increased activity of 
these proteases and observed difference of protein 
degradation between the skeletal and the cardiac 
muscle are discussed. 
2. Materials and methods 
Eight hyperthyroid and 9 normal male New Zealand 
white rabbits (1.0-l .5 kg body wt) received daily 
injections of either L-thyroxine (200 Mg/kg body wt) 
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or saline only for 2 weeks. After sacrificing the ani- 
mals, paravertebral skeletal muscle and cardiac muscle 
from both ventricles was rinsed with cold saline brief- 
ly, and the connective tissue was dissected away in 
icecold glass ware. All subsequent procedures were 
performed below 4°C. The muscle was minced, 
weighed, and lysosomal and cytosol fractions were 
prepared as in [ 121. Cathepsin B and D reside mainly 
in the lysosomal fraction [9,10], and the homogenate 
was divided into two parts. The supematant fraction, 
which could not be sedimented with the centrifuga- 
tion at 40 000 X g for 30 min in 0.25 M sucrose and 
10 mM K-phosphate buffer (pH 6.8), contained both 
the free cytosol fraction in vivo and the fraction which 
leaked from lysosome in the course of homogeniza- 
tion. Here, this fraction is termed ‘supernatant frac- 
tion’. The precipitate was suspended in 3 vol. 0.1% 
Triton X-100 to disrupt lysosome, and centrifuged at 
100 000 X g for 2 h. The resultant supernatant was 
termed ‘precipitate fraction’. Both fraction were used 
for the assay of cathepsin B and D activity, by the 
methods in [10,13]. 
One unit of cathepsin B activity was defined as 
1 nmol P-naphthylamine released from synthetic sub- 
strate, N+benzoxyl L-arginine /3-naphthylamide 
(Sigma), per minute at 37°C. One unit of cathepsin D 
activity/min at 37°C was defined as an increase of 
0.001 in A 750 after color development in the trichloro- 
acetic acid-soluble fraction by Lowry’s method [ 141. 
Another sample of muscle tissue was used for the 
assay of CANP. Muscle mince (3 .O g) was homoge- 
nized with a Virtis homogenizer at medium speed for 
15 s, with 4 bursts in 3 vol. 0.03 M KCl, 5 mM neu- 
tralized EDTA and 20 mM Na-phosphate buffer 
(pH 7.0), and centrifuged at 8000 X g for 30 min. 
The supematant was acidified to pH 4.7 by adding 
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1 N acetic acid, an essential step for separating the 
endogenous protease inhibitor from CANP [6,7,15]. 
The precipitate was suspended in equal volume of 
0.4 M Tris-HCl buffer (pH 7.4) and 1 mM EDTA, 
and centrifuged at 100 000 X g for 1 h. The resultant 
supernatant was used for the assay of CANP, follow- 
ing the method in [7]. 
Protein concentration was determined by the 
Biuret method with crystalline bovine serum albumin 
as a standard. Statistical analyses were performed by 
Student’s unpaied C-test. 
3. Results and discussion 
The whole body weight and weight of both ventri- 
cles were compared in the hyperthyroid and euthyroid 
group. After the administration of Lthyroxine for 
2 weeks, the whole body weight was reduced from 
1.28 f 0.08 (SEM) kg to 1 .OS f. 0.07 kg, while euthy- 
roid rabbits gained body weight from 1.45 f 0.13 kg 
to 1.65 f 0.12 kg. These changes between two groups 
were significant @< 0.01). Heart weight was not dif- 
ferent in the 2 groups (4.33 f 0.12 g in hyperthyroid 
group and 4.01 + O.il g in euthyroid group). 
3 .I. Lysosomal proteases activity in skeletal muscle 
As summarized in table 1, in skeletal muscle from 
the hyperthyroid group, the supematant fraction 
showed 1.7.times higher cathepsin B activity than the 
control group @ < 0.001). The precipitate fraction of 
hyperthyroid rabbits demonstrated 3 .l-times higher 
activity (JJ < O.OOl), and the total cathepsin B activ- 
ity per gram muscle was 2 S-times higher in hyperthy- 
roid group @ < 0.001). 
Relative to protein concentrations, cathepsin B 
activity in the hyperthyroid group also revealed higher 
values than the control group both in supematant and 
precipitate fractions (both p < 0.001). 
Cathepsin D activity was measured in the same 
fraction as cathepsin B. In the supematant fraction, 
the activity was 1.5.times higher in hyperthyroid rab- 
bits @ < 0.001, table l), whereas in the precipitate 
fraction, the activity increased 2.5.times in hyperthy- 
roid group @ < 0.00 1). Therefore, total cathepsin D 
activity per gram muscle weight was increased -2.fold 
in the hyperthyroid group @ < 0.005). 
Relative to protein concentrations, the hyperthy- 
roid rabbits demonstrated higher cathepsin D activity 
both in the supematant and precipitate fractions 
0, < 0.001). 
The increased activities of cathepsin B and D did 
not result from increased fragility of muscle lysosomes, 
since the activity retained in the lysosome f&tion 
was higher in hyperthyroid group @ < 0.005). 
The observed increases in protease activity are not 
due to decreased non-muscle weight, or to a selective 
decrease of proteins other than proteases, since activi- 
Table 1 
Effect of L-thyroxine administration on lysosomal protease activities in skeletal muscle 
Protease 
Cathepsin B 
Euthyroid (n = 6) Hyperthyroid (n = 5) 
Supernatant 3.91 * 0.12 6.52 +_ 0.35b 
Cell fraction Precipitate 4.82 f 0.47 15.02 f 1.50b unit/g muscle 
Total 8.73 * 0.53 21.54 f 1.4gb 
% Retained in lysosome 54.6 f 2.20 69.3 f 2.44a 
Cell fraction I Supernatant 0.238 * 0.009 0.367 f 0.023b 
Precipitate 0.272 * 0.026 0.844 f 0.043b unit/mg protein 
Cathepsin D 
Supernatant 41.0 f 3.8 64.8 f 2.4b 
Cell fraction Precipitate 69.0 f 
8.3 171.6 
i 
unit/g muscle 
Total 110.  10.4 236.4 f 5.0b I 7 1
% Retained in lysosome 60.9 f 2.52 72.6 f 0.42” 
Cell fraction Supernatant 2.52 f 0.23 3.62 f O.lib 
Precipitate 3.88 f 0.24 9.20 f 0.24b unit/mg protein 
Mean f SEM; a p < 0.005; b p < 0.001 
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Table 2 
Effect of L-thyroxine administration on calciumactivated neutral protease 
activity in either skeletal or cardiac muscle 
Muscle Euthyroid (n = 9) Hyperthyroid (n = 8) 
August 1980 
Skeletal 
Cardiac 
10.1 f 1.6 27.1 * 7.5a unit/g muscle 
4.53 f 0.64 9.13 * 2.07a unit/mg protein 
10.8 f 2.8 14.6 * 2.4 unit/g muscle 
3.55 f 0.84 3.27 f 0.55 unit/mg protein 
ties expressed both as per muscle weight and per mg 
protein increased. It is reasonable to assume that the 
increased activity is due to increased amount of 
enzymes. 
3.2. Calcium-activated neutral protease (CANPJ activ- 
ity in skeletal and cardiac muscle 
Table 2 summarizes the data of CANP activity. In 
skeletal muscle, CANP activity in hyperthyroid rabbits 
was 2.7-timeshigher @< 0.05) and the animal which 
showed the highest activity also had the greatest 
decrease in body weight (40%). In cardiac muscle, 
however, there was no difference between the two 
groups in CANP activity. 
Relative to protein concentrations, the hyperthy- 
roid skeletal muscle showed 2.fold higher CANP activ- 
ity than the control group @ < 0.05). Again, the 
activity in cardiac muscle was not different in the 2 
groups, and there was no signifrcant difference 
between the skeletal and the cardiac muscle in the 
euthyroid rabbits. 
This finding agrees well with other data showing 
that lysosomal protease activity in heart was not 
changed after the administration of Tq to the rat, even 
when it was increased in skeletal muscle [4]. Thus, 
the mechanism of thyroid hormone on protease syn- 
thesis and protein turnover appears different between 
the skeletal and cardiac muscle [ 161. 
We suggest that thyroid hormones may regulate 
myofibrillar protein degradation by altering the 
amount of proteases in skeletal muscle and not in car- 
diac muscle, and that the activities of endogenous 
proteases, which degrade ither contractile proteins 
(i.e., myosin and actin) or the regulatory proteins, 
(i.e., tropomyosin and troponin) [6,7,11], were 
increased in the skeletal muscle, resulting in muscle 
atrophy or muscle weakness. 
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